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Résumé en
anglais
Background: The reliable diagnosis rate of diagnostic tests is provided by their
intervals with acceptable accuracy (e.g. ≥90%) where a liver biopsy can be avoided.
Aims: To evaluate the overall accuracy and improve the reliable diagnosis rates of
blood tests for significant liver fibrosis. Methods: Five blood tests were compared
with Metavir fibrosis (F) staging in 1056 patients with chronic hepatitis C. Results:
Area under the receiver operating characteristics (F0-1 vs. F2-4) were: FibroMeter:
0.853, Fibrotest: 0.811, Fib-4: 0.799, aspartate aminotransferase to platelet ratio
index (APRI): 0.786 and Hepascore: 0.784 (P<10−3 between tests). The reliable
diagnosis rates based on two traditional intervals defined by thresholds ≥90% of
negative predictive values (NPV) and positive predictive values (PPV), diagnosing
F0/1 and F2/3/4, respectively, were: FibroMeter: 43.5%, APRI: 19.6%, Fibrotest:
17.1%, Hepascore: 3.9%, Fib-4: 1.7% (P<10−3). By dividing the indeterminate
interval by the diagnostic cut-off, two new intervals could be diagnosed reliably: F1/2
and F1/2/3. Accordingly, the reliable diagnosis rate was increased, e.g. FibroMeter:
75.5% (accuracy: 89.5%) with three intervals (F0/1, F1/2, F2/3/4). It was possible to
further increase this rate by using the more exportable 90% sensitivity/specificity
thresholds, e.g. FibroMeter: 90.2% (accuracy: 86.4%). By using the four intervals, the
reliable diagnosis rate was 100% (accuracy: 89.5% with predictive value (PV) and
87.5% with sensitivity/specificity). Conclusion: Reliable diagnosis is a diagnostic
index devoted to clinical practice. Its rate can be increased by creating new intervals
between diagnostic cut-off and 90% PVs or sensitivity/specificity thresholds. This
increased the overall accuracy from 78.1 to 89.5% and reduced the need for a liver
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